# Relit Biosciences

Explores biomarker-targeted imaging and radioligand approaches.

Author: Kevin Wimer
Canonical URL: https://kevinwimer.com/companies/relit-biosciences/
Stable ID: ca4a0e15-3c1e-4b1f-929e-e9e538b4b6ec
Revision: 9a1eea08-c8a8-405b-8c48-271a4ad162e1
Published: 2026-10-23T00:00:15.301Z
Updated: 2026-10-23T00:00:15.301Z
Reviewed: 2026-10-22

## Who this is for
For people comparing this service with their care team. Inclusion is not a recommendation or a finding that it is right for your cancer.

## Get specific before going further

1. Which imaging agent or treatment are we talking about, and what biomarker does it target?
2. Is this routine clinical care, a trial, or another investigational access route?
3. Which licensed clinical team would perform it, in what country, and under what authorization?
4. What evidence applies to my cancer, what would the result change, and what are the full costs?

Relit’s public website is brief. The parent company describes biomarker-targeted radioligand imaging. Sample requirements, patient eligibility, pricing and routine availability are not established by those pages.

## Limits and context
Service details are reported by the linked provider unless noted. Confirm current access, requirements and costs directly. A company profile does not establish clinical benefit.

## Relationships and disclosures
No paid placement. I have no investment, advisory role, paid partnership or other financial relationship with the twelve companies in this initial directory.

## Sources
- [Relit public overview](https://relit.bio/) — Relit Biosciences; official; checked 2026-10-22; The company’s stated focus on biomarker-based imaging and radiotherapeutics.
- [Even One Ventures portfolio](https://evenone.ventures/) — Even One Ventures; official; checked 2026-10-22; Parent-company description of Relit as biomarker-targeted radioligand imaging.

Organization website: https://relit.bio/

Information/access: [Relit website and contact](https://relit.bio/)

## Company facts
- **Focus:** Biomarker-based imaging and radioligand approaches. (Sources: relit, evenone)
- **Access:** Contact the company for the specific service and clinical access route. Its public overview does not describe a standard ordering process. (Sources: relit)

Topics: 
Capabilities: emerging-research

Related record IDs: f7221927-6b87-4be3-9a7c-906768a192a5, bcbf518f-872e-434c-b031-3d6c266ceaa4

Follow Kevin on X: https://x.com/kevinace

Educational information, not an individualized treatment recommendation.